Abstract:Oncolytic peptides represented potential novel candidates for anticancer treatments especially drug-resistant cancer cell lines. One of the most promising and extensively studied is LTX-315, which is considered as the first in class oncolytic peptide and has entered phase I/II clinical trials. Nevertheless, the shortcomings including poor proteolytic stability, moderate anticancer durability and high synthesis costs may hinder the widespread clinical applications of LTX-315. In order to reduce the synthesis costs, as well as develop derivatives possessing both high protease-stability and durable anticancer efficiency, twenty LTX-315-based derived-peptides were designed and efficiently synthesized. Especially, through solid-phase S-alkylation, as well as the optimized peptide cleavage condition, the derived peptides could be prepared with drastically reduced synthesis cost. The in vitro anticancer efficiency, serum stability, anticancer durability, anti-migration activity, and hemolysis effect were systematically investigated. It was found that derived peptide MS-13 exhibited comparable anticancer efficiency and durability to those of LTX-315. Strikingly, the D-type peptide MS-20, which is the enantiomer of MS-13, was demonstrated to possess significantly high proteolytic stability and sustained anticancer durability. In general, the cost-effective synthesis and stability-guided structural optimizations were conducted on LTX-315, affording the highly hydrolysis resistant MS-20 which possessed durable anticancer activity. Meanwhile, this study also provided a reliable reference for the future optimization of anticancer peptides through the solid-phase S-alkylation and L-type to D-type amino acid substitutions.

Synthesis and Biological Activities of N-Phosphoryl Branched Peptides

Synthesis of N-Phosphoryl Branched Peptides

Design, Synthesis and Biological Evaluation of Novel Non-peptide Boronic Acid Derivatives As Proteasome Inhibitors

Structural characterization of N-phosphoryl branched peptides

THE STUDY ON THE STRUCTURAL CHARACTERISTICS OF N-PHOSPHORYLATED BRANCHED PEPTIDE

Design, Synthesis and Biological Evaluation of Novel Tripeptidyl Epoxyketone Derivatives Constructed from Β-Amino Acid As Proteasome Inhibitors.

Synthesis and Biological Activity of Peptide Proline-Boronic Acids As Proteasome Inhibitors

Synthesis and Utilization of Chiral α-Methylated α-Amino Acids with a Carboxyalkyl Side Chain in the Design of Novel Grb2-SH2 Peptide Inhibitors Free of Phosphotyrosine

Bioactive Staurosporine Derivatives from the Streptomyces Sp. NB-A13.

Synthesis and Novel Properties of N-Phosphoryl Peptides

Branched -helical peptides enhanced antitumor efficacy and selectivity

Design, Synthesis, and Antitumor Activity Study of All-Hydrocarbon-Stapled B1-Leu Peptides

Synthesis and Biological Evaluation of Novel All-Hydrocarbon Cross-Linked Aza-Stapled Peptides.

Structural basis for a non-phosphorus-containing cyclic peptide binding to Grb2-SH2 domain with high affinity.

The antibacterial properties of branched peptides based on poly(l-arginine): In vitro antibacterial evaluation and molecular dynamic simulations

Total Synthesis and Modification of Proline-Rich Cyclopeptides Phakellistatins 17 and 18 Isolated from Marine Sponge

Functional Properties of a Novel Hybrid Antimicrobial Peptide NS: Potent Antitumor Activity and Efficient Plasmid Delivery.

Synthesis and structural optimization of oncolytic peptide LTX-315

Synthesis and Preliminary Studies of Biological Activity

Antibacterial and Anti-Inflammatory Activity of Branched Peptides Derived from Natural Host Defense Sequences

Synthesis and Antitumor Activity of Α-Aminophosphonate Derivatives Containing Thieno[2,3-D]pyrimidines